Bank of America Corp DE decreased its position in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 1.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,371,960 shares of the medical research company's stock after selling 14,392 shares during the quarter. Bank of America Corp DE owned approximately 0.90% of Bruker worth $80,424,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Sterling Capital Management LLC lifted its stake in shares of Bruker by 29.0% in the 4th quarter. Sterling Capital Management LLC now owns 3,514 shares of the medical research company's stock valued at $206,000 after purchasing an additional 791 shares during the period. Merit Financial Group LLC acquired a new position in shares of Bruker in the 4th quarter valued at $300,000. Bank of New York Mellon Corp lifted its stake in shares of Bruker by 7.6% in the 4th quarter. Bank of New York Mellon Corp now owns 988,863 shares of the medical research company's stock valued at $57,967,000 after purchasing an additional 69,806 shares during the period. Blue Trust Inc. lifted its stake in shares of Bruker by 13.5% in the 4th quarter. Blue Trust Inc. now owns 2,164 shares of the medical research company's stock valued at $127,000 after purchasing an additional 257 shares during the period. Finally, Wells Fargo & Company MN lifted its stake in shares of Bruker by 95.1% in the 4th quarter. Wells Fargo & Company MN now owns 190,855 shares of the medical research company's stock valued at $11,188,000 after purchasing an additional 93,048 shares during the period. Institutional investors and hedge funds own 79.52% of the company's stock.
Wall Street Analysts Forecast Growth
BRKR has been the topic of a number of analyst reports. Barclays cut their price target on Bruker from $50.00 to $46.00 and set an "overweight" rating on the stock in a research note on Thursday, May 8th. Citigroup lowered their price objective on shares of Bruker from $75.00 to $50.00 and set a "buy" rating for the company in a research report on Monday, April 7th. Guggenheim restated a "buy" rating on shares of Bruker in a research report on Monday, February 24th. The Goldman Sachs Group lowered their price objective on shares of Bruker from $50.00 to $45.00 and set a "neutral" rating for the company in a research report on Thursday, May 8th. Finally, Stifel Nicolaus lowered their price objective on shares of Bruker from $57.00 to $48.00 and set a "hold" rating for the company in a research report on Thursday, May 8th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat.com, Bruker presently has a consensus rating of "Moderate Buy" and a consensus target price of $60.10.
Check Out Our Latest Stock Analysis on BRKR
Bruker Stock Up 2.3%
Shares of NASDAQ BRKR traded up $0.84 during mid-day trading on Friday, hitting $37.53. The company had a trading volume of 1,786,228 shares, compared to its average volume of 1,604,384. The company has a market capitalization of $5.69 billion, a PE ratio of 49.38, a price-to-earnings-growth ratio of 2.16 and a beta of 1.23. The firm has a 50-day simple moving average of $40.33 and a two-hundred day simple moving average of $50.45. The company has a current ratio of 1.60, a quick ratio of 0.77 and a debt-to-equity ratio of 1.15. Bruker Co. has a one year low of $34.10 and a one year high of $78.94.
Bruker (NASDAQ:BRKR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The medical research company reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.01. The company had revenue of $801.40 million during the quarter, compared to analysts' expectations of $763.83 million. Bruker had a return on equity of 21.01% and a net margin of 3.36%. Bruker's revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.53 EPS. On average, equities analysts expect that Bruker Co. will post 2.69 EPS for the current year.
Bruker Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, June 27th. Investors of record on Monday, June 16th will be paid a $0.05 dividend. The ex-dividend date is Monday, June 16th. This represents a $0.20 annualized dividend and a yield of 0.53%. Bruker's dividend payout ratio (DPR) is currently 38.46%.
Bruker Company Profile
(
Free Report)
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
Further Reading
Before you consider Bruker, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bruker wasn't on the list.
While Bruker currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
